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Abstract
Pathogenic protein accumulation and spread are fundamental principles of neurodegenera-
tive diseases and ultimately account for the atrophy patterns that distinguish these diseases
clinically. However, the biological mechanisms that link pathogenic proteins to specific neu-
ral network damage patterns have not been defined. We developed computational models
for mechanisms of pathogenic protein accumulation, spread and toxic effects in an artificial
neural network of cortical columns. By varying simulation parameters we assessed the
effects of modelled mechanisms on network breakdown patterns. Our findings suggest that
patterns of network breakdown and the convergence of patterns follow rules determined by
particular protein parameters. These rules can account for empirical data on pathogenic pro-
tein spread in neural networks. This work provides a basis for understanding the effects of
pathogenic proteins on neural circuits and predicting progression of neurodegeneration.
Introduction
Accumulation of pathogenic protein in neural tissue is the core process underpinning neuro-
degenerative brain pathologies and ultimately responsible for their phenotypic consequences.
An emerging paradigm of neurodegeneration emphasises the propagation of pathogenic pro-
teins across neural networks, leading to consistent spatiotemporal profiles of regional brain
dysfunction and atrophy that can be mapped macroscopically using neuroimaging techniques
[1–4]. Certain features of pathogenic proteins such as conformational misfolding and the pro-
pensity to ‘template’ the conversion of normal protein to pathogenic form favour the spread of
proteinopathies [5] while in vitro seeding and animal inoculation studies suggest that protein
spread co-opts neural circuitry [6, 7]. It has been proposed that neurodegenerative phenotypes
are the result of specific conjunctions of pathogenic protein and neural circuit characteristics:
‘molecular nexopathies’ [3]. However, the mechanisms that link protein accumulation to neu-
ral network breakdown are still poorly understood. Elucidating these mechanisms would
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Human neuroimaging techniques are remote from the local tissue effects that induce neu-
rodegeneration while in vitro and in vivo systems are resource-and time-intensive. Computa-
tional approaches would potentially allow rapid evaluation of neurodegeneration models and
derivation of relevant parameters of protein accumulation and spread. Most computational
research on these diseases has focused on classification and prediction of atrophy [2, 8] rather
than the elucidation of underlying mechanisms. However, computational modelling
approaches are potentially of much wider utility, as illustrated by previous work applying such
methods to study the aggregation of amyloid-beta and tau in Alzheimer’s disease and evaluate
therapeutic interventions [9].
Here we describe a computational modelling approach to simulate mechanisms of patho-
genic protein accumulation, spread and toxic effects within an artificial small neural network.
Using the NEURON simulator software [10], we simulated an artificial neural network com-
prised of cortical columns [11], a representative and frequent target of neurodegenerative dis-
eases [12]. This network has been previously used to simulate pathological neuronal
communication in Parkinson’s disease and Alzheimer’s disease [13, 14]. We addressed the
general hypothesis that this model would generate protein and network dependent disease
effects, in line with empirical data for protein spread and macroscopic disease behavior. The
molecular nexopathies paradigm predicts that structural features of neural circuits confer vul-
nerability to particular pathogenic proteins [3]. To test this hypothesis, we ran simulations,
systematically varying protein and network parameters and we defined metrics that relate
these parameter variations to protein spread and the network damage pattern.
All computational models entail simplifying assumptions. For example, pathogenic proteins
often possess a number of conformational isoforms [15], but we reduced this variation to
model a normally folded and a pathogenically misfolded variant. We modelled protein solubil-
ity and misfolding properties, shown in vivo to be key determinants of cell integrity and sur-
vival [15]. In addition, we modelled protein spread through passive diffusion, active transport
and synaptic transfer, all of which are characteristics relevant to network spread [3, 4, 6, 7].
Identification of disease-specific network signatures is challenging in the presence of stochastic
variation (observed for example, between brain atrophy profiles of individual patients). Here
we used time to convergence of simulations to assess how robustly and consistently protein
and network parameters contribute to establishing patterns of spread. The null hypothesis (no
effect of modifying protein and network parameters on spread) would predict no convergence
between simulations. We also assessed how these parameters affect neural network survival
and asymmetry of network damage (key features of protein spread in real neural networks
[3, 6]).
Materials and methods
We used NEURON, a simulator for neural networks [10] and focused our simulations on the
interaction between pathogenic protein and cortical columns [12], based on the neural net-
work used by Neymotin et al. [11]. This network had K = 3 cortical columns, each with 470
neurons (N = 1410 total). Each neuron i 2 {1, . . ., N}, belongs to a cortical column Col(i) = {1,
2, 3}, to a layer Lay(i) = {2, 4, 5, 6} and has a type which can be excitatory Regular Spiking (RS),
excitatory Intrinsically Bursting (IB), inhibitory Fast Spiking (FS) or inhibitory Low-Threshold
Spiking (LTS), Type(i) = {RS, IB, FS, LTS}. Each neuron is modelled with 3 cylindrical ele-
ments, called sections: one for its dendrites (j = 1), one for its soma (j = 2) and one for the
axon (j = 3). A concentration of non-pathogenic (normal) protein Cnti;j and pathogenic
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(misfolded) protein Cpti;j exists within each section at time t. We set Cmax = 1 as the maximum
concentration, i.e. Cnti;j þ Cp
t
i;j  Cmax. Many neuronal properties and the neural network’s
connectivity have been defined by Neymotin et al. [11] and for our purposes we defined the
diameter Di,j, length Li,j, base area Ri,j = π(Di,j/2)2 and volume Vi,j = Li,j × Ri,j of each section, as
well as ri;j!i;j as the strength of a synapse starting from neuron i, connecting to the postsynaptic
neuron i, section j. If there is no synaptic connection, then ri;j!i ;j ¼ 0. We defined pi;j!i;j as the
intrinsic tendency of protein to spread selectively via intercolumnar synaptic connections (the
projection neurons for each column), which drive protein spread across the network. Fig 1 is a
schematic representation of a simulated neuron.
We modelled protein production, misfolding, clearance, passive diffusion, active transport,
synaptic transfer, a toxic effect on the firing frequencies of neurons, neuronal toxicity (overall
damage to the neuron) and neuronal death. These processes were applied for all neurons, at
every timestep (simulation iteration), in the aforementioned order and we use the notation
Cnt;ti;j and Cp
t;t
i;j to signify intermediate updates to the concentrations, where τ indicates an
intermediate timestep. Except for misfolding, these processes were applied in the same manner
for both normal and pathogenic proteins. Therefore, henceforth we will only refer to patho-
genic protein (readers can assume similar equations for normal protein).
Simulation setup
Common settings for all simulations were: timestep interval dt = 0.025msec, passive diffusion
fraction fpd = 0.05, production and clearance rates RPn = RCn = 0.0002, RPp = RCp = 0.00002 and
normal concentration levels Cnn = Cpn = 0.01. We ran 11016 simulations, varying eight param-
eters: 1) two random instances of neural network connectivities based on the connection den-
sities in Table 2 of Lytton et al. [11]; 2) soluble/clearable (there is evidence suggesting soluble
tau and amyloid-beta oligomers are toxic, whereas larger, insoluble aggregates are not toxic
[16]) or insoluble/unclearable pathogenic protein (in the latter case there is no clearance and
negligible production of pathogenic protein); 3) 17 types of seeds—in the first three types
(Seed All 1, 2 or 3) all neurons start with Cnt¼0i;j ¼ Cp
t¼0
i;j ¼ 0:01 in simulations with soluble
pathogenic protein and Cnt¼0i;j ¼ 0:01;Cp
t¼0
i;j ¼ 0:0001 with insoluble pathogenic protein (the
difference between these three seeds was variation in the random number generation of NEU-
RON)—for the remaining types of seeds we added extra pathogenic protein at the start of the
simulation to a single neuron of the first cortical column, varying the cortical layer and neuro-
nal type of the seeded neuron (Seed L2RS); 4) low misfolding rate RM = 0.08 or high misfolding
rate RM = 0.09; 5) no diffusion, low diffusion speed σz = 50 or high diffusion speed σz = 500; 6)
no active transport fat = 0, weak active transport fat = 0.0001 or strong active transport
fat = 0.001; 7) three settings for synaptic transfer and the toxic effect of the pathogenic
Fig 1. A visual representation of a simulated neuron and its section parameters.
https://doi.org/10.1371/journal.pone.0192518.g001
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protein—no synaptic transfer fst = 0 with an increase of voltage thresholds Vth adapti , low synap-
tic transfer fst = 1 with an increase of voltage thresholds or high synaptic transfer fs t = 1 with a
decrease of voltage thresholds (since a decrease of voltage thresholds increases firing frequen-
cies, this indirectly strengthens the synaptic transfer mechanism); 8) tendency to avoid inter-
columnar connections pi;j!i;j ¼ 0:01, no spread selectivity pi;j!i ;j ¼ 1 or tendency to spread via
intercolumnar connections pi;j!i ;j ¼ 100.
Production
Pathogenic protein could in general be created by the processes either of transcription and
translation (production) and/or by post-translational modification (misfolding) of normal
protein. We assumed production remains at a specific rate of protein molecules per unit of
time (with little variation), which is unaffected by protein accumulation [17], until cellular
death. We modelled production as anti;j, ap
t
i;j (Eq 1), which were samples from normal distribu-
tions, based on mean production rates RPn, RPp:
apti;2  N ðRPp;RPp
2Þ; apti;1 ¼ ap
t
i;3 ¼ 0 ð1Þ
Cpt;1i;j ¼ Cpti;j þ ap
t
i;j ð2Þ
Misfolding
Generally, the proteins associated with neurodegeneration are misfolded from a soluble to an
insoluble state, with a number of intermediates and it is primarily larger aggregates that cause
normal protein to misfold [18]. We hypothesised that normal protein is misfolded when it
comes in close proximity to pathogenic protein [3, 7, 15]. To derive a model based on our
hypothesis, we simulated a cube volume, within which we added normal and pathogenic pro-
tein molecules and let them diffuse. Normal protein molecules would misfold and become
pathogenic whenever they came in close proximity. At the end of the simulation we calculated
the concentration of normal protein molecules that misfolded. We repeated this simulation
varying the initial number of normal and pathogenic protein concentrations. Considering sim-
ulation results (Fig 2, left) as ground truth, our proposed model of the product of the two
Fig 2. Left: Concentration of normal protein (Cn) misfolded to pathogenic (Cp) based on simulations. Right:
Proposed misfolding model: RM  Cn  Cp, with RM = 1. Adjusting RM can negate the scaling difference.
https://doi.org/10.1371/journal.pone.0192518.g002
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concentrations (Eq 3, Fig 2, right), was in close agreement with the ground truth:
bti;j ¼ RMCn
t
i;jCp
t
i;j ð3Þ
Cnt;2i;j ¼ Cn
t;1
i;j   bti;j
Cpt;2i;j ¼ Cp
t;1
i;j þ bti;j
ð4Þ
Clearance
Protein accumulation is caused by an imbalance between overall protein production and clear-
ance due to three mutually compatible scenarios: (a) clearance mechanisms remain healthy, but
insoluble pathogenic proteins accumulate, (b) clearance mechanisms remain healthy, but are
overwhelmed by the accumulation of protein due to other mechanisms, or (c) clearance mecha-
nisms weaken, reducing clearance rates [19, 20]. We modelled protein clearance such that the
concentration of every protein variant tends to be maintained at a normal level within a cell.
When protein levels are below or above normal, production rates remain unchanged, but clear-
ance rates adapt to return protein levels to normality. Given clearance rates RCn, RCp at normal
levels of protein concentration Cnn, Cpn, the protein clearance terms qnti;j, qp
t
i;j (Eq 5) were:
qpti;j  N ðm
t
Cp; m
t
Cp
2Þ ð5Þ
mtCp ¼ RCp log 1þ ðe   1Þ
Cpti;j
Cpn
 !
ð6Þ
Cpt;3i;j ¼ Cp
t;2
i;j   qpti;j; ð7Þ
where mtCn, m
t
Cp are considered as the adaptive clearance rates. Although our choice of a logarith-
mic function is somewhat arbitrary, it is adaptive to the concentration levels and biologically
plausible.
Normal and pathogenic protein equilibrium
The equilibrium between normal and pathogenic protein concentrations is commonly
hypothesised to be lost in some neurodegenerative diseases [21]. We ran simulations with nor-
mal and pathogenic protein concentration at a single point, varying the misfolding rate RM to
observe behavioural differences on the protein equilibrium (Fig 3). When RM = 0.0626, the
protein concentrations reached equilibrium, but after a small number of timesteps this equilib-
rium was lost. When RM = 0.0624, the same process occurred, but the equilibrium was lost
after a larger number of timesteps. When RM = 0.622, the equilibrium was maintained after a
much larger number of timesteps. Notably, the behaviour of this process is sensitive to small
changes to RM. While these were simple simulations, biochemical variations of this kind could
contribute to individual variation in vulnerability to neurodegenerative diseases. Protein
aggregation may occur all the time, but in most individuals, neurons may be able to degrade
small soluble aggregates, preventing the formation of large insoluble aggregates [18]. Tau
strains that seed more efficiently (i.e. have a high misfolding rate) may be significantly more
toxic to cells that express high levels of monomeric tau [22]. These simulations demonstrate
how these two hypotheses could be true.
Computational modelling of pathogenic protein spread in neurodegenerative diseases
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Spread
There are many hypotheses regarding the spread of pathogenic proteins [7, 15, 23] (e.g. diffu-
sion, exocytosis, etc.). Proteins spread primarily through the neural network [16, 24], in either
anterograde or retrograde fashion [24]. We modelled intracellular and intercellular passive dif-
fusion, intracellular active transport and intercellular synaptic transfer. We defined fpd, fat and
fst as fractions, restricting the maximum protein quantity that can spread out of a neuronal sec-
tion within a single timestep for passive diffusion, active transport and synaptic transfer
respectively. Based on available empirical data [18, 25], we modelled both normal and patho-
genic protein spread via the same mechanisms.
Passive diffusion. We modelled passive diffusion of protein as Brownian motion,
restricted to the cylindrical shape of neuronal sections intracellularly and the synapses and
their synaptic strengths intercellularly. We defined zi;j!i;j (Eq 10) as the fraction of Cp
t;3
i;j that
diffuses past the boundary of section i, j and enters a neighbouring section i,j. These coeffi-
cients comprise four terms: 1) yi;j!i;j models Brownian motion in the primary spatial dimen-
sion by taking the integral of the one-dimensional normal distribution with its mean at the
centre of i, j and its standard deviation σz controls the speed of passive diffusion (Eq 8); 2) the
ratio of the area of the entrance to the source’s base area Ri,j accounts for the other two spatial
dimensions; 3) predetermined weights wi;j!i ;j had values equal to the synaptic strengths for
intercellular spread or were set arbitrarily to a high value for intracellular spread; 4) the intrin-
sic spread selectivity of the protein pi;j!i ;j .
yi;j!i ;j ¼
1
ffiffiffiffiffi
2p
p
Z
  Li;j
2sz
  1
e
x2
2 dx; if i;j neighbour of i; j ð8Þ
wi;j!i ;j ¼
20; if i ¼ i
ri;j!i;j ; if i 6¼ i
(
ð9Þ
Fig 3. Three simulations showing the equilibrium between normal and pathogenic protein within a single volume,
in conjunction with our modelled production, misfolding and clearance, with different misfolding rates RM. The
initial protein concentrations are Cn = 0.05, Cp = 0.01, the normal concentration levels are Cnn = 0.05, Cpn = 0.01 and
the production and clearance rates are RPn = RCn = 4e − 4, RPp = RCp = 0.8e − 4. Left: RM = 0.0626. Middle: RM = 0.0624.
Right: RM = 0.622. Note the different time scales.
https://doi.org/10.1371/journal.pone.0192518.g003
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zi;j!i ;j ¼ yi;j!i ;j
min ðRi;j;Ri ;jÞ
Ri;j
wi;j!i ;jpi;j!i ;j ð10Þ
However, this model spreads protein to neighbouring neuronal sections only and not to
every geodesically nearby section. We calculated coefficients di;j!i;j , indicating what fraction of
Cpt;3i;j spreads to section i, j using the following approach: choose a source section i,j and spread
fractions of Cpti;j to its neighbour sections based on zi ;j!i;j. Then, iterate the following: if the
amount of protein that a neighbour section received is above a threshold tsig, repeat the process
for every such section as a source, spreading the quantity those sections received, until conver-
gence to an equilibrium. The updated concentrations are (Eq 13):
xtk ¼ Cp
t;3
i;j Vi;j ð11Þ
Mk;l ¼
fpddi;j!i ;j ; k 6¼ l
1   fpd þ fpddi;j!i ;j ; k ¼ l
(
ð12Þ
Cpt;4i;j ¼
Mk;:xt
Vi;j
; ð13Þ
where k ¼ 3ði   1Þ þ j; l ¼ 3ði   1Þ þj and the notation Mk,: is the row vector consisting of
the elements of the k-th row of M.
Active transport. We modelled active transport based on data for the axonal transport of
tau protein [24, 26], a relevant pathogenic protein in many neurodegenerative diseases. We
concluded that tau shows anterograde movement, no movement and retrograde movement
15.4%, 73%, 11.6% of the time, respectively. Due to lack of evidence for transport rates in den-
drites and somas, we adjusted these percentages for all neuronal sections, favouring antero-
grade movement. We defined eti;j!i ;j as the fraction of protein that is actively transported from
i, j to i,j at time t.
Cpt;5i;j ¼
P
j e
t
i;j!i;jCp
t;4
i;j Vi;j
Vi;j
ð14Þ
Synaptic transfer. We hypothesised that every action potential transfers a large quantity
of protein to postsynaptic neurons. There is evidence that more tau (250% increase [25]) and
amyloid-beta are released from neurons when those neurons are actively stimulated [16, 25].
We defined gti;j!i ;j as the fraction of protein that is synaptically transferred when an action
potential occurs.
gti;j!i;j ¼
0:154fstpi;j!i ;j ri;j!i;j
P
~i
P
~jpi;j!~i;~j ri;j!~i ;~j
ð15Þ
Cptþ1i;j ¼
P
i
P
j g
t
i;j!i;jCp
t;5
i ;j Vi;j
Vi;j
ð16Þ
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Neuronal toxicity, toxic effects and cellular death
We assumed that the toxicity level within neurons, txcti (starting at 0), increases due to protein
accumulation, based on an exponential function of the protein concentration (Eq 17). There
are many hypotheses regarding the toxic effects of pathogenic proteins [3, 21, 23]. Amyloid-
beta may cause hyperexcitability [16, 25], whereas tau causes synaptic loss [16]. We modelled
that neuronal toxicity causes a toxic effect on the voltage threshold Vth adapti [11] required for
triggering an action potential. As neuronal toxicity increases, the threshold either increases,
indirectly reducing firing frequencies (toxic loss of function) or decreases, indirectly increasing
firing frequencies (toxic gain of function). Once toxicity reached txctii ¼ 1, we assumed cellular
death occurred at time ti, after which only the processes of misfolding and diffusion out of the
neuron would continue.
txcti ¼ txc
t  1
i þ 0:001 exp 10
X
j
Cnti;j þ Cp
t
i;j
3
 !
  1
 !
ð17Þ
Results metrics
SSGi ¼
X
8ini;8j;8j
ri;j!i ;j  
X
8ini;8j;8j
ri ;j!i;j ð18Þ
Ds;sðnÞ ¼
#fGsðnÞ \ GsðnÞg
n ð19Þ
tcðs;sÞ ¼ arg min
n
jDs;sðnÞ   tconvj;
s:t: Ds;sðmÞ  tconv; 8m 2 ftcðs;sÞ; . . . ;Ng
ð20Þ
CONVij ¼
P
s2Hi
P
s2Hj
tcðs;sÞ
jHijjHjj
ð21Þ
ASY ¼ max
t
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
P
iðtxc
t
i  
P
jtxc
t
j=NÞ
2
N   1
s
ð22Þ
Results
We ran 11016 simulations, varying eight parameters (see Simulation Setup under Materials
and methods): network connectivity, protein seed location, pathogenic protein solubility, mis-
folding rate, passive diffusion speed, active transport rate, synaptic transfer and the tendency
of protein to spread selectively via intercolumnar synaptic connections (predicted to be a key
determinant of the pattern of circuit breakdown [3]).
In order to assess the vulnerability of specific neurons we calculated for each neuron its
Geodesic Distance to the Seed (GDS) and its “Synaptic Strength Gradient” (SSG, Eq 18), which
is the difference between the sum of its presynaptic connection strengths and the sum of its
postsynaptic connection strengths. Neurons with a high SSG have many and strong presynap-
tic connections, but few and weak postsynaptic connections (here termed ‘bottleneck’
Computational modelling of pathogenic protein spread in neurodegenerative diseases
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neurons). Modulation of information transfer between input and output connections is a basic
concept of neuron biology and neurons have widely varying input:output relations [27]. We
hypothesised that neurons with a high SSG or a low GDS value are more vulnerable and reach
cellular death earlier. In Fig 4, every neuron is plotted as a point, using their respective SSG
and GDS values against the simulation time that they reached cellular death; we performed lin-
ear regression and calculated R2 values in order to assess the relation between these neuronal
characteristics and time to cellular death. We will refer to SSG R2 as the ‘bottleneck’ neuron
survival characteristic and to GDS R2 as the distance to seed survival characteristic.
We quantified the asymmetry of network damage ASY by taking the maximum value over
time of the standard deviation of the neuronal toxicity (Eq 22). We assume that a high varia-
tion in neural network damage is similar to what one would call asymmetric neural network
damage. This maximum value typically occurred during the first few cellular deaths. We
also calculated the time it took for all neurons to reach cellular death (time to network break-
down—TTNB) in each simulation. Table 1 indicates the magnitude of the effect each parame-
ter had on SSG R2, GDS R2, ASY and TTNB.
Fig 4. Each point indicates a neuron i, at the time of its cellular death ti and its respective SSGi (left) or GDSi
(right) value for simulations primarily driven by passive diffusion of pathogenic protein (seed L2FS, low
misfolding rate, strong active transport, no synaptic transfer and no spread selectivity). (a) SSG and (b) GDS with
soluble pathogenic protein. (c) SSG and (d) GDS with insoluble pathogenic protein.
https://doi.org/10.1371/journal.pone.0192518.g004
Computational modelling of pathogenic protein spread in neurodegenerative diseases
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In order to assess each parameter’s impact on protein spread patterns, we quantified the
similarity and time to convergence between the order of cellular deaths for all pairs of simula-
tions. Given a pair of simulations s and s, we created the sets Gsn;G
s
n; n 2 f1; :::;Ng (N is total
number of neurons), indicating the set of the first n neurons to reach cellular death in simula-
tion s, s. We calculated the Dice coefficient (a measure of similarity between two sets)Ds;sðnÞ
(Eq 19) between sets Gsn, G
s
n for n 2 {1, . . ., N}. The higher the Dice coefficient value between
two sets, the larger the number of dead neurons in common between the sets. We defined time
to convergence as the time tcðs;sÞ (Eq 20), normalised by N, that the Dice coefficient reached
and continued to exceed a high threshold value tconv = 0.8. After convergence, since the Dice
coefficient remains high, the two simulations show similar spread patterns. Simulations with a
low tcðs;sÞ (i.e. early convergence) have similar spread patterns during the entire simulation.
Fig 5 summarises the time to convergence for all pairs of simulations. We created the sets
Hi, i 2 {1, . . ., 35}, each of which includes all simulations with one common parameter value
indicated by the underscript i. The value of i is indicated on the i-th row of the y-axis of Fig 5.
For example, all simulations with a ‘Low misfolding rate’ belong to set H22. We computed a
matrix CONV 2 R3535, where element CONVij is the mean time to convergence between all
simulations in set Hi against all simulations in set Hj (Eq 21). Comparing diagonal elements
illustrates the effect of a single protein mechanism on time to convergence, whereas by com-
paring non-diagonal elements within a row or a column one can study how variation of a sec-
ond protein mechanism affects time to convergence.
Fig 6 displays the mean firing frequencies and toxicity over time for certain neuron types in
a simulation with an increase of firing voltage thresholds toxic effect.
Discussion
Across simulations, passive diffusion was the primary driver of the spread patterns (Fig 5),
strongly influencing neuronal survival characteristics based on distance to seed (GDS) and
synaptic input:output relations (SSG) as well as the asymmetry of network breakdown (Fig 4,
Table 1); in combination with soluble protein, spread patterns showed a relationship with the
input:output (SSG) metric, whereas with insoluble protein spread patterns showed a relation-
ship with the distance to seed (GDS) metric. Assuming a primarily anterograde spread of pro-
tein, our findings suggest that a high SSG value (high neuronal input:output) may confer
Table 1. Impact of simulation parameters on ‘bottleneck’ neuron survival characteristic (SSG R2), distance to seed
survival characteristic (GDS R2), spread asymmetry (ASY) and time to network breakdown (TTNB). Number of
+/- signs indicate strength of impact on the metric compared to a baseline observation, with 0 indicating no impact. 1
N/A since initial protein seed concentrations were different (see Materials and methods; for similar seeds, TTNB
would be much higher with soluble pathogenic protein). 2 The first three seeds had higher values. 3 Layer 4 and 5 seeds
had lower values, whereas layer 6 had highest values. 4 , indicates the relationships: [tendency of pathogenic protein
to avoid intercolumnar connections vs no spread selectivity], [tendency of pathogenic protein to spread via interco-
lumnar connections vs no spread selectivity].
Parameter SSG R2 GDS R2 ASY TTNB
1) Network connectivity 0 0 0 0
2) Protein insolubility −− ++ ++ N/A1
3) Seed location 2 3 0 0
4) Misfolding rate 0 0 + −
5) Diffusion speed +++ +++ ++ 0
6) Active transport strength ++ + ++ −−
7) Synaptic transfer strength ++ + ++ +
8) Spread selectivity4 +++, + −−, −− +, +++ 0, 0
https://doi.org/10.1371/journal.pone.0192518.t001
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vulnerability to the neurodegenerative process, rather than general connectedness (high neu-
ronal input+output), which is typically considered [4] a determinant of neuronal survival. This
accords with recent formulations assigning the diffusive spread of pathogenic proteins a cen-
tral role in the evolution of neurodegenerative proteinopathies [1–5, 15] and with evidence
from animal models of protein propagation [6].
Increased misfolding rate and active transport of pathogenic protein hastened network
breakdown, consistent with an amplification of intracellular toxic effects, as predicted empiri-
cally [5, 6, 28]. A higher misfolding rate hastened neurodegeneration (reduced TTNB) far
more than a higher initial seed concentration in the case of insoluble pathogenic protein, in
agreement with in vivo data [22].
The asymmetry of network breakdown increased with insoluble protein, increased misfold-
ing, diffusion speed, active transport, synaptic transfer or when protein had the tendency to
spread selectively via intercolumnar connections: these mechanisms tend to ‘focus’ neuronal
toxicity in particular neurons, a mechanism previously proposed to underpin the strikingly
asymmetric atrophy profiles of TDP-43-opathies [3]. In addition, inspection of Fig 5 suggests
that the conjunction of particular protein and network factors promoted more rapid conver-
gence of patterns of network breakdown, in keeping with a molecular nexopathy mechanism
[3]. Pathogenic protein solubility, higher diffusion speed, stronger active transport and synap-
tic transfer and any spread selectivity all consistently accelerated convergence of the spread
pattern.
Our findings endorse an important role of local neuronal geometry in modulating network
breakdown (Figs 4, 5 and 6, Table 1). Whereas changing the overall network connectivity had
Fig 5. Heatmap of mean time to convergence between all pairs of simulation sets Hi (e.g. a value of 0.65 indicates
that convergence occurred after 65% of neurons reached cellular death). The x-axis labels are replicated from the y-
axis labels.
https://doi.org/10.1371/journal.pone.0192518.g005
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no effect, the laminar location of seeded neurons importantly affected the pathogenic protein
spread pattern. This might suggest a computational basis for the exquisite histopathological
selectivity and regional vulnerability that characterise a range of neurodegenerative diseases
[1–6, 15, 23]. Although our simulations were not designed primarily to capture alterations in
neuronal electrophysiology, the relatively simple model parameters yielded complex neuronal
activity profiles that showed a dependence both on neuronal type and time. For example,
L4LTS neurons showed an initial increase in firing frequency under a ‘loss of function’ toxic
effect (Fig 6), potentially due to the removal of inhibitory effects from connected neurons and
in line with previous predictions based on biological disease models [23].
Especially pertinently, our simulations identify factors that might constitute targets for ther-
apeutic manipulation. For example, increased diffusion speed in the context of a soluble patho-
genic protein tended to prolong overall network survival. This follows as faster diffusion
spreads protein more evenly in the network, promoting overall clearance of soluble pathogenic
protein: a potential therapeutic mechanism that has attracted much recent interest [19, 20, 28].
Similar considerations may apply to synaptic transfer of pathogenic protein, which was also
protective (Table 1) and has also been proposed as a target for future interventions [14]. In
Alzheimer’s disease, amyloid-beta is associated with toxic hyperexcitability [16, 29] (which in
turn leads to even more pathogenic protein to be released from affected neurons). Our synap-
tic transfer mechanism was protective for individual neurons with a high firing frequency, but
in combination with the hyperexcitability toxic gain effect, it was protective on the entire net-
work-scale (increase of TTNB, Table 1) for both soluble and insoluble pathogenic protein. Alz-
heimer’s disease is the result of a complex interplay between amyloid-beta and tau proteins:
the neuronal loss caused by tau coupled with the neuronal hyperexcitability caused by amyloid
beta could have the effect of spreading tau outside zones of amyloid deposition, leading to dif-
ferential tissue distributions of the two proteins, in line with recent cellular and neuroimaging
data [29, 30].
Conclusion
Here we have shown that modelled pathogenic protein mechanisms and network properties
drive patterns of network breakdown in a simulated cortical neural network. Crucially,
Fig 6. Mean toxicity and firing frequencies over time for layer 4 neurons of the first cortical column, grouped by
neuronal type.
https://doi.org/10.1371/journal.pone.0192518.g006
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modification of protein and network parameters produced consistent and convergent patterns
of protein spread, rather than random sequences of cellular deaths.
The potential of computational modelling techniques to simulate neural network disinte-
gration remains largely unexplored. Such techniques seem ideally suited to define the ‘struc-
tural logic that governs the biological effects’ of neurodegenerative pathologies [22]. Our
findings suggest that a small artificial neural network under a handful of relevant parameters
can generate diverse, biologically plausible behaviour that is broadly relevant to human neuro-
degenerative diseases and consistent with empirical data.
A major limitation of all such modelling approaches is the need to simplify (sometimes rad-
ically) in order to capture a few mechanisms of pathogenic proteins which are likely to be of
general relevance. There are a number of ways in which our model should be refined in future
work. Some important factors that we have not addressed here, but which are likely to contrib-
ute to the pathogenesis of neurodegenerative diseases, include chaperone proteins, glial cell
interactions with neurons, protein aggregates of different sizes and the recruitment of addi-
tional proteins by larger aggregates, protein spread via the extracellular compartment and the
operation of intracellular endosomes. Each of these could potentially be assessed in developing
our model further and making it a more realistic simulation of the complexity of actual neuro-
degenerative diseases. However, we believe that even in the simplified approach presented
here, computational modelling approaches show promise in assisting in the development of
future diagnostic tools. If such approaches identify candidate properties of pathogenic proteins
that drive neural network breakdown, then this in principle would allow culprit proteins to be
inferred from particular profiles of network breakdown that are observed empirically (for
example, using brain imaging).
Further work is required to test the model against a range of diseases and data derived in
vitro and from animal models. By fitting the model to such data, one can derive which specific
parameters and models are likely to govern each individual pathogenic protein. As computa-
tional models are continually refined based on new neurobiological findings (e.g. production
of protein per neuron per unit of time), this framework could quickly and easily test a variety
of hypotheses regarding pathogenic proteins, so that further neurobiological research can
focus on hypotheses which were found to be more likely to be true. The ultimate goal will be to
determine how computational models of micro-circuits scale to whole-brain anatomical pro-
files of human disease, at which scale neuroimaging can be used as validation to learn which
parameters and models represent each neurodegenerative disease. This framework will poten-
tially be able to predict neurodegenerative disease progression, based on protein and neural
network characteristics and assess the impact of candidate modulatory factors, with clear
implications for rational drug discovery.
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